An orally administered bifunctional gastrointestinal coating has been developed and shown to limit nutrient absorption through the bowel mucosa ultimately lowering blood glucose and also acting as a platform for delivery of drugs to the gastrointestinal tract.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zheng, Y., Ley, S. H. & Hu, F. B. Nat. Rev. Endocrinol. 14, 88–98 (2017).
Lee, Y. et al. Nat. Mater. https://doi.org/10.1038/s41563-018-0106-5 (2018).
Schauer, P. R. et al. New Engl. J. Med. 376, 641–651 (2017).
Fuhrmann, K. & Fuhrmann, G. Curr. Opin. Colloid Interface Sci. 31, 67–74 (2017).
McCarville, J. L., Caminero, A. & Verdu, E. F. Curr. Opin. Pharmacol. 25, 7–12 (2015).
Fuhrmann, G. et al. Nat. Chem. 5, 582–589 (2013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fuhrmann, G. Luminal coating of the intestine. Nature Mater 17, 754–755 (2018). https://doi.org/10.1038/s41563-018-0143-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-018-0143-0